Deborah J. Moonan, RN, BSN, Director, Continuing Education & Grants, has disclosed that she has no relevant financial relationships.
Ann Gianola, MA, Manager, Continuing Education & Grants, has disclosed that she has no relevant financial relationships.
Kristina M. Gregory, RN, MSN, OCN, Vice President, Clinical Information Operations, has disclosed that she has no relevant financial relationships.
Rashmi Kumar, PhD, Senior Manager, Clinical Content, has disclosed that she has no relevant financial relationships.
Jillian L. Scavone, PhD, Oncology Scientist/Medical Writer, has disclosed that she has no relevant financial relationships.
Ishak KG, Sesterhenn IA, Stromeyer FW. Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 32 cases. Hum Pathol 1984;15:839–852.
Makhlouf HR, Ishak KG, Goodman ZD. Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. Cancer 1999;85:562–582.
Bioulac-Sage P, Laumonier H, Laurent C. Benign and malignant vascular tumors of the liver in adults. Semin Liver Dis 2008;28:302–314.
Dean PJ, Haggitt RC, O’Hara CJ. Malignant epithelioid hemangioendothelioma of the liver in young women. Relationship to oral contraceptive use. Am J Surg Pathol 1985;9:695–704.
Singhal S, Jain S, Kar P. Multifocal epithelioid hemangioendothelioma of liver after long-term oral contraceptive use-a case report and discussion of management difficulties encountered. J Gastrointest Cancer 2009;40(1-2):59–63.
Mehrabi A, Kashfi A, Schmidt J. Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer 2006;107:2108–2121.
Wang LR, Zhou JM, Zhao YM. Clinical experience with primary hepatic epithelioid hemangioendothelioma: retrospective study of 33 patients. World J Surg 2012;36:2677–2683.
Miller WJ, Dodd GD III, Federle MP. Epithelioid hemangioendothelioma of the liver: imaging findings with pathologic correlation. AJR Am J Roentgenol 1992;159:53–57.
Lyburn ID, Torreggiani WC, Harris AC. Hepatic epithelioid hemangioendothelioma: sonographic, CT, and MR imaging appearances. AJR Am J Roentgenol 2003;180:1359–1364.
Bruegel M, Muenzel D, Waldt S. Hepatic epithelioid hemangioendothelioma: findings at CT and MRI including preliminary observations at diffusion-weighted echo-planar imaging. Abdom Imaging 2011;36:415–424.
Mistry AM, Gorden DL, Busler JF. Diagnostic and therapeutic challenges in hepatic epithelioid hemangioendothelioma. J Gastrointest Cancer 2012;43:521–525.
Thomas RM, Aloia TA, Truty MJ. Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma. HPB (Oxford) 2014;16:677–685.
Marino IR, Todo S, Tzakis AG. Treatment of hepatic epithelioid hemangioendothelioma with liver transplantation. Cancer 1988;62:2079–2084.
Madariaga JR, Marino IR, Karavias DD. Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol 1995;2:483–487.
Cardinal J, de Vera ME, Marsh JW. Treatment of hepatic epithelioid hemangioendothelioma: a single-institution experience with 25 cases. Arch Surg 2009;144:1035–1039.
Lerut JP, Orlando G, Adam R. The place of liver transplantation in the treatment of hepatic epithelioid hemangioendothelioma: report of the European liver transplant registry. Ann Surg 2007;246:949–957.
Grotz TE, Nagorney D, Donohue J. Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option? HPB (Oxford) 2010;12:546–553.
Sangro B, Iñarrairaegui M, Fernández-Ros N. Malignant epithelioid hemangioendothelioma of the liver successfully treated with sorafenib. Rare Tumors 2012;4:106–109.
Stacher E, Gruber-Mösenbacher U, Halbwedl I. The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: new potential therapeutic targets? Lung Cancer 2009;65:49–55.
Emamaullee JA, Edgar R, Toso C. Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: implications for treatment and surgical management. Liver Transpl 2010;16:191–197.
Chevreau C, Le Cesne A, Ray-Coquard I. Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO). Cancer 2013;119:2639–2644.
Aksoy EA, Atalar B, Beylergil V. Unresectable epithelioid hemangioendothelioma of the neck region cured by radiotherapy. J Med Cases 2011;2:147–150.